BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 17027892)

  • 1. Type-I interferons and systemic lupus erythematosus.
    Koutouzov S; Mathian A; Dalloul A
    Autoimmun Rev; 2006 Oct; 5(8):554-62. PubMed ID: 17027892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interleukin 10 in disseminated lupus erythematosus].
    Emilie D
    J Soc Biol; 2002; 196(1):19-21. PubMed ID: 12134628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I interferon in systemic lupus erythematosus and other autoimmune diseases.
    Banchereau J; Pascual V
    Immunity; 2006 Sep; 25(3):383-92. PubMed ID: 16979570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic susceptibility to polyI:C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice.
    Jørgensen TN; Thurman J; Izui S; Falta MT; Metzger TE; Flannery SA; Kappler J; Marrack P; Kotzin BL
    Genes Immun; 2006 Oct; 7(7):555-67. PubMed ID: 16900204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the genetic basis and immunopathogenesis of systemic lupus erythematosus from the study of mouse models.
    Cheung YH; Loh C; Pau E; Kim J; Wither J
    Semin Immunol; 2009 Dec; 21(6):372-82. PubMed ID: 19926489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic lupus erythematosus: all roads lead to type I interferons.
    Pascual V; Farkas L; Banchereau J
    Curr Opin Immunol; 2006 Dec; 18(6):676-82. PubMed ID: 17011763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease.
    Fairhurst AM; Wandstrat AE; Wakeland EK
    Adv Immunol; 2006; 92():1-69. PubMed ID: 17145301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I interferons are involved in the development of ultraviolet B-induced inflammatory skin lesions in systemic lupus erythaematosus patients.
    Reefman E; Kuiper H; Limburg PC; Kallenberg CG; Bijl M
    Ann Rheum Dis; 2008 Jan; 67(1):11-18. PubMed ID: 17502354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interferon-alpha: a key cytokine in systemic lupus erythematosus pathogenesis].
    Mathian A; Koutouzov S
    Rev Med Interne; 2008 Sep; 29(9):696-700. PubMed ID: 18524426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [B-cell anomalies in systemic lupus erythematosus].
    Tron F; Jacquot S; Gilbert D
    Ann Med Interne (Paris); 2002 Dec; 153(8):503-12. PubMed ID: 12610424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I interferon and lupus.
    Rönnblom L; Alm GV; Eloranta ML
    Curr Opin Rheumatol; 2009 Sep; 21(5):471-7. PubMed ID: 19525849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmunity and chronic inflammation - two clearance-related steps in the etiopathogenesis of SLE.
    Muñoz LE; Janko C; Schulze C; Schorn C; Sarter K; Schett G; Herrmann M
    Autoimmun Rev; 2010 Nov; 10(1):38-42. PubMed ID: 20817127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis.
    Lood C; Gullstrand B; Truedsson L; Olin AI; Alm GV; Rönnblom L; Sturfelt G; Eloranta ML; Bengtsson AA
    Arthritis Rheum; 2009 Oct; 60(10):3081-90. PubMed ID: 19790049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environment and systemic lupus erythematosus: an overview.
    Sarzi-Puttini P; Atzeni F; Iaccarino L; Doria A
    Autoimmunity; 2005 Nov; 38(7):465-72. PubMed ID: 16373251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
    Yao Y; Richman L; Higgs BW; Morehouse CA; de los Reyes M; Brohawn P; Zhang J; White B; Coyle AJ; Kiener PA; Jallal B
    Arthritis Rheum; 2009 Jun; 60(6):1785-96. PubMed ID: 19479852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DcR3 as a diagnostic parameter and risk factor for systemic lupus erythematosus.
    Han B; Bojalil R; Amezcua-Guerra LM; Springall R; Valderrama-Carvajal H; Wu J; Luo H
    Int Immunol; 2008 Aug; 20(8):1067-75. PubMed ID: 18562337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genetics of type I interferon in systemic lupus erythematosus.
    Bronson PG; Chaivorapol C; Ortmann W; Behrens TW; Graham RR
    Curr Opin Immunol; 2012 Oct; 24(5):530-7. PubMed ID: 22889593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell biology and dysfunction in SLE.
    Anolik JH
    Bull NYU Hosp Jt Dis; 2007; 65(3):182-6. PubMed ID: 17922667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th1/Th2 balance of SLE patients with lupus nephritis.
    Nakashima H; Akahoshi M; Masutani K
    Rinsho Byori; 2006 Jul; 54(7):706-13. PubMed ID: 16913661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I interferon signature in systemic lupus erythematosus.
    Bezalel S; Guri KM; Elbirt D; Asher I; Sthoeger ZM
    Isr Med Assoc J; 2014 Apr; 16(4):246-9. PubMed ID: 24834763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.